Application of preoperative MRI lesion identification algorithm in pediatric and young adult focal cortical dysplasia-related epilepsy
•MELD algorithm has variable performance across novel pediatric/young adult datasets.•MELD algorithm has high sensitivity for FCDIIB.•MELD algorithm has high sensitivity for FCD Type II in neonatal/infantile patients.•MELD algorithm has clinical utility in simulated real world MRI-negative populatio...
Saved in:
Published in | Seizure (London, England) Vol. 122; pp. 64 - 70 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.11.2024
|
Subjects | |
Online Access | Get full text |
ISSN | 1059-1311 1532-2688 1532-2688 |
DOI | 10.1016/j.seizure.2024.09.024 |
Cover
Summary: | •MELD algorithm has variable performance across novel pediatric/young adult datasets.•MELD algorithm has high sensitivity for FCDIIB.•MELD algorithm has high sensitivity for FCD Type II in neonatal/infantile patients.•MELD algorithm has clinical utility in simulated real world MRI-negative population.
The purpose of this study was to evaluate the performance and generalizability of an automated, interpretable surface-based MRI classifier for the detection of focal cortical dysplasia.
This was a retrospective cohort incorporating MRIs from the epilepsy surgery (FCD and MRI-negative) and neuroimaging (healthy controls) databases at Children's National Hospital (CNH), and a publicly-available FCD Type II dataset from Bonn, Germany. Clinical characteristics and outcomes were abstracted from patient records and/or existing databases. Subjects were included if they had 3T epilepsy-protocol MRI. Manually-segmented FCD masks were compared to the automated masks generated by the Multi-centre Epilepsy Lesion Detection (MELD) FCD detection algorithm. Sensitivity/specificity were calculated.
From CNH, 39 FCD pharmacoresistant epilepsy (PRE) patients, 19 healthy controls, and 19 MRI-negative patients were included. From Bonn, 85 FCD Type II were included, of which 68 passed preprocessing. MELD had varying performance (sensitivity) in these datasets: CNH FCD-PRE (54 %); Bonn (68 %); MRI-negative (44 %). In multivariate regression, FCD Type IIB pathology predicted higher chance of MELD automated lesion detection. All four patients who underwent resection/ablation of MELD-identified clusters achieved Engel I outcome.
We validate the performance of MELD automated, interpretable FCD classifier in a diverse pediatric cohort with FCD-PRE. We also demonstrate the classifier has relatively good performance in an independent FCD Type II cohort with pediatric-onset epilepsy, as well as simulated real-world value in a pediatric population with MRI-negative PRE. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1059-1311 1532-2688 1532-2688 |
DOI: | 10.1016/j.seizure.2024.09.024 |